Genetic Variants in Idiopathic Premature Ovarian Insufficiency

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-39
SponsorAbdurrahman Hamdi İnan

About this trial

Premature ovarian insufficiency is a condition in which ovarian function decreases or is lost before the age of 40 years. In many patients, the underlying cause remains unexplained. This prospective observational case-control study aims to investigate pathogenic and likely pathogenic genetic variants in DNA repair and meiotic genes related to ovarian reserve and folliculogenesis in women with idiopathic premature ovarian insufficiency.

The study will include women younger than 40 years with idiopathic premature ovarian insufficiency and age- and ethnicity-matched control participants with normal ovarian function. Clinical and reproductive data will be collected, and a peripheral blood sample will be obtained from each participant for whole exome sequencing. The frequency of pathogenic or likely pathogenic variants will be compared between the case and control groups. No investigational drug, device, or treatment intervention will be administered.

Eligibility criteria

Qualifiers

Women aged 18 to 39 years.

Spontaneous amenorrhea or marked menstrual irregularity lasting at least 4 months.

Serum FSH level greater than 25 IU/L. In cases of diagnostic uncertainty, FSH measurement may be repeated after 4 to 6 weeks.

Diagnosis of idiopathic premature ovarian insufficiency, with no known chromosomal abnormality, FMR1 premutation, defined syndromic genetic diagnosis, or iatrogenic cause.

Disqualifiers

Known chromosomal abnormality, such as Turner syndrome or structural X chromosome abnormality.

FMR1 premutation carrier status.

Previously defined syndromic genetic diagnosis.

Active malignancy.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

100 Participants
are grouped into 2 trial groups

Sponsors and collaborators

Abdurrahman Hamdi İnan

Lead sponsor

Tepecik Training and Research Hospital

Sponsor institution